These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 17319859)
1. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Yoder BJ; Wilkinson EJ; Massoll NA Breast J; 2007; 13(2):172-9. PubMed ID: 17319859 [TBL] [Abstract][Full Text] [Related]
2. The role of E-cadherin in low-grade ductal breast tumourigenesis. Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841 [TBL] [Abstract][Full Text] [Related]
3. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063 [TBL] [Abstract][Full Text] [Related]
4. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes. Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811 [TBL] [Abstract][Full Text] [Related]
6. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438 [TBL] [Abstract][Full Text] [Related]
7. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma. Jaffer S; Orta L; Sunkara S; Sabo E; Burstein DE Hum Pathol; 2007 Jun; 38(6):864-70. PubMed ID: 17350670 [TBL] [Abstract][Full Text] [Related]
9. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168 [TBL] [Abstract][Full Text] [Related]
10. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma]. Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Wahed A; Connelly J; Reese T Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484 [TBL] [Abstract][Full Text] [Related]
12. B7-h4 is highly expressed in ductal and lobular breast cancer. Tringler B; Zhuo S; Pilkington G; Torkko KC; Singh M; Lucia MS; Heinz DE; Papkoff J; Shroyer KR Clin Cancer Res; 2005 Mar; 11(5):1842-8. PubMed ID: 15756008 [TBL] [Abstract][Full Text] [Related]
13. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas. de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma]. Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181 [TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas? Rosa M; Mohammadi A; Masood S Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472 [TBL] [Abstract][Full Text] [Related]
17. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases? Goldstein NS Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785 [TBL] [Abstract][Full Text] [Related]
18. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Buerger H; Mommers EC; Littmann R; Diallo R; Brinkschmidt C; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Böcker W Am J Clin Pathol; 2000 Dec; 114(6):854-9. PubMed ID: 11338473 [TBL] [Abstract][Full Text] [Related]
19. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers]. Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]